Drugs / Anbeizhu
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07009470 | Feb 2025 → Apr 2028 expected | hepatocellular carcinoma | Tongji Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anbeizhu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07009470 ↗ |